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Abstract
Background: Symptomatic spinal metastasis from an intracranial primary 
glioblastoma multiforme (GBM) is very rare. Our literature search identified a total 
of 42 such patients of which 11 were treated with surgical decompression for spinal 
metastasis with only one such report from the pediatric age group. Previous studies 
have reported variable outcomes after surgical management.
Case Description: We report the case of a 16‑year‑old boy who underwent 
surgical spinal decompression for spinal metastasis after intracranial GBM. The 
patient regained motor and autonomic function following surgery and reported 
improvement in pain. We also present findings from a literature review using the 
PubMed database from 1985 to June 2013 on this subject and compare radiation 
therapy with surgical decompression as palliative modalities in such patients.
Conclusion: There are no evidence‑based guidelines available on the subject 
and no treatment regimen has yet demonstrated survival benefit in these patients. 
Surgical decompression may be a better option for patients with focal resectable 
lesions and who are medically stable to tolerate the procedure.
Key Words: Decompression, glioblastoma multiforme, laminectomy, metastasis, 
palliation, spinal cord compression, surgery
INTRODUCTION
Glioblastoma multiforme (GBM) is the most common 
primary malignant brain tumor.[3,22] It arises mostly from 
astrocytes but may also derive from oligodendrocytes.[11] 
The peak incidence is at 54 years of age and increases 
thereafter.[11] The incidence among 18‑ to 24‑year‑olds 
is about 1 per million and it is even lesser in younger 
children.[11] The reported incidence of extra cranial 
metastasis in these tumors is between 0.4% and 0.5%.[15] 
Leptomeningeal and spinal metastasis are even rarer with 
a relatively poor prognosis.[12,21,24] Our literature search 
identified a total of 42 reported cases of spinal drop down 
metastasis following GBM and only 11 of these patients 
underwent a surgical spinal decompression. There has 
only been one such case reported from the pediatric age 
group.[11] We report the case of a 16‑year‑old boy who was 
initially diagnosed and treated for a left parietooccipital 
GBM and then developed spinal metastasis for which 
he underwent surgical spinal decompression. We also 
review the literature on the efficacy of spinal surgical 
decompression on clinical outcomes in these patients and 
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report and compare outcomes in patients who received 
surgical decompression with those who did not.
CASE REPORT
This 16‑year‑old male child presented with spontaneous 
onset of headache, nausea, and slight drowsiness 
since 2 weeks. The neurological examination revealed 
intact higher mental functions and no cerebellar 
signs. However, there was a bitemporal heteronymous 
hemianopia confirmed by perimetry. Power in right 
upper and lower limb was 4/5 according to Medical 
Research Council (MRC) scale with positive pronator 
drift.[17] The gait was otherwise normal. Magnetic resonance 
imaging (MRI) showed a left parietooccipital lesion with 
intraventricular extension [Figure 1]. Both solid and cystic 
components were present with calcifications marked on 
the medial aspect. The patient underwent a craniotomy 
with neuronavigation‑guided biopsy of the mass and gross 
total excision. Intraoperatively, a soft‑firm mildly vascular 
lesion was identified, which was clearly demarcated in 
most dimensions. A frozen section confirmed the diagnosis 
of World Health Organization (WHO) grade IV GBM and 
this was consistent with the final histopathology report. 
The tumor was Glial fibrillary acidic protein (GFAP) 
and s‑100 positive and 40% of the cells showed 
nuclear positivity with MIB‑1 antibody to the Ki‑67 
antigen (MIB‑1). Postoperatively, the patient developed 
a subtle sensory aphasia. The rest of the hospital course 
was unremarkable and the patient was discharged in 
stable condition. The patient received postoperative local 
radiotherapy with a total dose of 54 grays (Gy).
Eight months later the patient presented with acute onset 
bilateral lower limb paraplegia. There was a complete 
loss of sensation in dermatome thoracic 7 (T‑7) and T‑8. 
Abdominal and cremasteric reflexes were absent. The 
power was 0/5 with increased spasticity and 3+ reflexes 
and normal bulk in both the lower limbs.[17,25] The 
Babinski’s sign was positive bilaterally and the patient 
had lost bladder control. An MRI showed recurrence 
of GBM with multifocal cranial deposits [Figure 2] 
and spinal MRI showed an intradural extramedullary 
mass measuring 1.1 × 5.0 cm in anterioposterior (AP) 
and craniocaudal dimensions at T‑5 to T‑7 level with 
significant cord compression [Figure 3].
The patient underwent a T5‑T7 laminectomy and excision 
of metastatic mass. Intraoperatively, a fragile highly vascular 
intradural extramedullary mass was noticed and sent for 
histopathology analysis. The histopathological examination 
of the mass revealed multiple fragments of a cellular 
tumor with hemangiopericytomatous vasculature. The cells 
revealed hyperchromatic round to oval nuclei with scant 
cytoplasm [Figure 4]. Increased mitotic figures and glycogen 
were also seen. On immunohistochemical staining, the 
mass was focally positive for GFAP, epithelial membrane 
antigen (EMA), cluster of differentiation 99 (CD 99) and 
Vimentin [Figure 5]. The MIB‑1 was raised and a diagnosis 
of metastatic GBM was made. Postoperatively, the patient 
showed recovery of autonomic function and the power 
was 3/5 in both the lower limbs, which gradually improved 
to 5/5 over the next one month. The patient was given 
postoperative radiotherapy with a total dose of 28 Gy.
Three months later, the patient presented to the 
emergency room (ER) with fever of 39°C and seizures 
since 3 days. He also complained of urinary and fecal 
incontinence. We evaluated him for these complaints 
with urine culture, which grew Escherichia coli and 
Psuedomonas and the patient was given appropriate 
Figure 1: (a) CT scan head; (b-d) T1-contrast enhanced MRI showing 
a left parietooccipital lesion with intraventricular extension. Both 
solid and cystic components can be appreciated with calcifications 
on the medial aspect
a b
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Figure 2: (a-c) T1-contrast enhanced MRI head performed 6 months postoperatively suggestive of recurrent disease
b ca
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supportive care and antibiotics and discharged from the 
hospital once in stable condition.
Three weeks later, the patient presented with severe 
pain in right arm and loss of sensation, which now 
involved both the upper arms. The family signed a do 
not resuscitate (DNR) form and the patient passed 
away 2 days later following cardiopulmonary arrest after 
significant brain stem herniation and extension of GBM.
DISCUSSION
The incidence of symptomatic spinal metastasis from a 
primary intracranial metastasis has been reported between 
1% and 2.7%.[2,21,24] The exact number maybe even higher 
as GBM is a rapidly progressive disease in which many 
patients probably die before spinal metastasis become 
symptomatic. Technological advances have slightly 
improved the life expectancy of patients with GBM and 
increased use of MRI may lead to a higher incidence 
being reported in the future.
The exact mechanism for intramedullary spread 
remains unclear.[20] A probable pathway of dissemination 
includes invasion of the basement membrane and 
choroid plexus. This theory is supported by reports in 
literature where increased incidence is associated with 
tumor presence proximal to ventricular structures and 
craniotomies.[7] However, dissemination has been known 
to occur even without a craniotomy[1,10,16] and many studies 
have found that tumor proximity to ventricular system is 
not an independent risk factor for spinal metastasis.[6,20] 
The immunocompromised status from adjuvant radiation 
and chemotherapy may render these patients more prone 
to metastatic disease.[20] The spread of GBM has also 
been reported along white matter tracts.[8] Mutations in 
the tumor suppressor gene PTEN, higher MIB‑1 labeling 
index and GFAP expression have been associated with a 
higher risk for intramedullary metastasis.[13,15,20] Neurological 
symptoms such as back pain, gait disorders, sensory and 
motor deficits are common in patients with drop metastasis 
and depend on the segment of the cord affected and the 
long tracts, which are compromised.[23] The most common 
neurological deficit is paraperesis.[23] Spinal metastasis is 
reported to occur 5‑13 months after the diagnosis of primary 
intracerebral glioma.[10,21] The median time from diagnosis 
of GBM to death is less than 2 years.[20] The median 
time from diagnosis of spinal metastasis to death was one 
month, with only one patient surviving for 5 months.[21] 
Our patient passed away within a year of diagnosis of GBM 
and about 4 months after symptomatic spinal metastasis, 
which is consistent with reports in literature.
The overall survival after a diagnosis of GBM has only 
marginally improved over the decades. The addition of 
temozolomide has improved the 5 year survival rate to about 
10% as opposed to 1.9% with radiation alone.[22] Despite 
temozolamide, 70% of the patients die within 2 years 
of diagnosis.[22] Our patient did not receive adjuvant 
chemotherapy with temozloamide despite recommendation 
because of financial constraints. This raises questions as to 
the extent of palliative measures that should be adopted 
in resource‑deprived developing countries and severely 
hampers our ability to care for these very sick patients.
Consensus exists that younger age and good neurological 
status at presentation confer better outcomes.[21] Adjuvant 
chemotherapy, radiotherapy, and total tumor resection 
have been shown to increase life expectancy in patients 
with GBM.[21] The molecular genetics of GBM may be the 
most important determinant of patient outcomes. Patients 
with O6‑methylguanine‑DNA methyltransferase (MGMT) 
promoter methylation have a 2‑year survival of 48.9% and 
5‑year survival of 13.8%, as compared with 14.8% and 8.3%, 
respectively, among those with unmethylated MGMT.[14]
Many authors have recommended the use of 
steroids.[20,23] We also administered steroids to our 
patient. The outcomes following steroid administration 
are variable and mostly depend on the outcomes of 
adjuvant radiotherapy and treatment with temozolomide. 
Figure 4: Sheets of atypical cells with hyperchromatic nuclei and 
increased mitosis (H and E stain, ×400)
Figure 3: (a) Sagittal section T-2 MRI showing lesion at T5-T7 
levels resulting in significant cord compression. (b) Axial section 
T-2 MRI (with magnification tool of PACS) showing an intradural 
extra-medullary mass compressing the spinal cord
a b
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However, it seems reasonable to use steroids in acute 
settings till appropriate guidelines become available.
At present no evidence‑based radiation schedule exists 
for spinal metastasis of GBM.[23] Authors have previously 
described using radiation doses of 20, 21, 30, and 39 Gy. 
This has generally been of limited advantage in terms 
of regaining lost function or survival benefit.[10,12,19,20,23] 
However, some authors have reported good palliative 
outcomes in terms of pain relief.[12]
Surgical spinal decompression with laminectomy has only 
been described in some case reports[4,5,9,11,23,24] [Table 1]. 
Out of the 11 cases that we found during our literature 
search, there were 5 male and 5 female patients (gender of 
1 patient was not mentioned). The median age at the time 
of surgery was 34 years (inter‑quartile range; IQR = 43.5). 
Three patients received chemotherapy for their spinal 
metastasis, while eight patients received radiation therapy. 
Overall, good palliative outcomes were described in 
six (54.5%) patients, three (27.3%) patients did not have 
improvement in symptoms, while the outcomes could not 
be determined for two (18.2%) patients. At the same time, 
we identified 31 patients who received radiation therapy 
or concomitant chemoradiotherapy (CCRT) for their 
spinal metastasis. Out of these 31 patients, pain relief was 
significant in only 6 patients (19.4%), no improvement was 
noticed in 16 patients (51.6%), while outcomes could not 
be determined for 9 patients (29%). In comparison, less 
than 20% of the patients who underwent radiation therapy 
alone reported improvement in symptoms. Our patient 
also reported significant improvement in symptoms 
following a surgical spinal decompression. However, this 
sample size is too small for any meaningful statistical 
analysis. Moreover, the reports are compiled over more than 
25 years and the efficacy of radiation and chemotherapy 
has changed over time. Also there may be a selection bias 
favoring those patients for surgical decompression who 
have focal resectable lesions and are in a relatively better 
medical condition. In our opinion, treatment should be 
individualized for every case till uniform evidence‑based 
guideline becomes available on the subject.
Table 1: Previous reports of spinal metastasis with GBM and outcomes[2,4,5,9‑11,18,23,24]
Author (year) Age (sex) Spinal segment 
effected
Symptoms Chemotherapy Radiotherapy Improvement 
in symptoms
Khan et al. (current report) 16, M Thoracic Paraplegia, loss of sensation in 
T7‑T8
No Yes Yes
Amitendu et al., 2012 63, F Lumbar Bilateral sciatica, lower limb 
weakness, lower limb weakness
No No Yes
27, M Sacral Right sided sciatica No No Yes
Tinchon et al., 2012 Not 
known
Thoracic Paraparesis, autonomic dysfunction 
and sensory level
Yes Yes Yes
Arzbaecher et al., 2007 63, F Thoracic Paraplegia, T6 sensory level, 
absent lower extremity reflexes, 
gait ataxia, and bowel incontinence
Yes Yes No
Jahraus et al., 2003 6, F Cervical, Thoracic 
and Lumbar
Bilateral lower extremity 
paraperesis
Yes Yes No
Hubner et al., 2001 36, F Cervical, Lumbar 
and Sacral
Paraparesis, Bladder incontinence No No Unknown
Hamilton et al., 1993 70, M Thoracic Urinary incontinence, paresthesia 
and lower limb weakness, sensory 
level at T10
No Yes Yes
Vertosick et al., 1990 21, F Thoracic Paraparesis No Yes No
Onda et al., 1986 42, M Cervical Weakness of lower extremities, 
flaccid paraplegia, sensory 
impairment below T9, dysuria
No Yes Unknown
Bukeo et al., 1985 32, M Thoracic Paraplegia, urinary incontinence No Yes Unknown
GBM: Glioblastoma multiforme
Figure 5: The tumor cells are diffusely positive for GFAP 
immunostain (×400)
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CONCLUSION
No evidence‑based guidelines have yet been developed 
due to the rare incidence of spinal metastasis from a 
GBM and no treatment regimen has yet demonstrated 
survival benefit. Treatment modalities need to be 
individualized to the needs and resources of the patients 
and hospitals. Surgical decompression may be a better 
option for patients with resectable focal lesions who are 
medically stable to tolerate the procedure.
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